Vera Therapeutics, Inc.
We are a clinical-stage biotechnology company developing treatments that transform patients’ lives.
Brisbane, United States
349 employees
Post Ipo Equity
Biotechnology, Health Care
General Information
Get notified when Vera Therapeutics, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Vera Therapeutics, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Vera Therapeutics, Inc.
Taxonomy: clinical-stage, therapeutics, gene-editing technology, immunological diseases, genetic disorders, biologic therapeutics, clinical potential, sickle cell disease, cystic fibrosis, precision medicine
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | •••••• | - | 28 Oct 2024 | |
| Post-IPO Equity | •••••• | - | 29 Jan 2024 | |
| Post-IPO Equity | •••••• | - | 01 Feb 2023 | |
| Post-IPO Equity | •••••• | - | 10 Feb 2022 | |
| Debt Financing | •••••• | - | 01 Jan 2021 |
Vera Therapeutics, Inc. Alternatives & Competitors
Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therape...
A leading precision oncology company focused on synthetic lethality
We Use Small Molecules To Modify RNA Splicing
FAQ About Vera Therapeutics, Inc.
Don't just browse. Track.
Signal Tracker monitors Vera Therapeutics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
